BridgeBio has substantially boosted this progress of the new solution for amyloid heart disease, employing Attruby. Preliminary patient results indicates significant benefits for patients affected from this debilitating https://bridgebio172899.blogprodesign.com/63567871/company-advances-cardiac-amyloidosis-management-using-the-therapy